ClinicalTrials.gg
Sign In

Gastrointestinal Diseases clinical trials

The registry lists 548 studies for Gastrointestinal Diseases across more than 10 countries. 101 are recruiting or about to start. 210 of them are mainly about Gastrointestinal Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 101 narrower conditions too, such as Colorectal Neoplasms: 28,303 studies, 6,928 open.

ClinicalTrials.gov finds 47,358 studies for Gastrointestinal Diseases. How that becomes 547 here

This page counts the studies the registry files under Gastrointestinal Diseases, and those it files under no condition that list Gastrointestinal Diseasesthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 47,358Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −25,711Filed under a narrower condition, counted on its own pageColorectal Neoplasms 6,086 · Stomach Neoplasms 2,802 · Crohn Disease 1,891 · Colonic Neoplasms 1,395 · Rectal Neoplasms 1,288 · Esophageal Neoplasms 1,213 · 91 more
  3. −27List Gastrointestinal Diseases as a condition, but the registry did not file them under itMost often written as “Cystic Fibrosis Gastrointestinal Disease” (6), “H.Pylori Gastrointestinal Disease” (3), and “Gastrointestinal Disorder Postoperative” (2). The registry filed 17 of them under no condition at all, and the others under other conditions only, most often Cystic Fibrosis (6) and Food Hypersensitivity (1).
  4. −21,073Match it another way25 name it in the title, 5 in a keyword, and 21,043 by a synonym or other text the search reads.
  5. 547The count on this page

Get an email when these change. Save the Gastrointestinal Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
304
Status unknown
76
Recruiting
65
Terminated
32
Active, not recruiting
23
Not yet recruiting
21

Phase

Phase 2
83
Phase 3
55
Phase 1
34
Phase 4
20
Early Phase 1
3

Where

United States
200
China
60
Italy
40
Canada
40
Spain
35
United Kingdom
35

Who runs them

Karolinska Institutet (10) · National Center for Research Resources (NCRR) (9) · Boston Children's Hospital (7) · AstraZeneca (7) · Massachusetts General Hospital (6) · Mayo Clinic (6) · Renmin Hospital of Wuhan University (6) · Exact Sciences Corporation (6)

What is being tested here

Drugs under test in Gastrointestinal Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Lactobacillus rhamnosus202
GSK1070806202
Probiotic125
Budesonide124
Glepaglutide122
Catequentinib hydrochloride102
Anlotinib102
Glutens102
Lacticaseibacillus casei101
Bifidobacterium bifidum101

Drug classes tested here Immune checkpoint inhibitors 3 open · Tyrosine kinase inhibitors (TKIs) 2 open · Corticosteroids 1 open · Antimetabolites 8 · Proton pump inhibitors (PPIs) 8

Coming up

7phase 3 studies under way
35studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 65 Gastrointestinal Diseases studies recruiting now, 30 (46%) set no upper age limit and 22 (34%) stop at 75 or younger. 18 (28%) take children under 18. 1 (2%) are for women only and 1 (2%) for men only; 20 (31%) take healthy volunteers.

Recruiting studies that take each age, of 65
AgeWomenMen
1010 (15%)10 (15%)
1856 (86%)56 (86%)
3052 (80%)53 (82%)
4051 (78%)52 (80%)
5051 (78%)52 (80%)
6549 (75%)50 (77%)
7546 (71%)47 (72%)
8538 (58%)39 (60%)

Across all 548 studies, recruiting or not: 45% stop at 75 or younger and 32% at 65; 29% take children; 2% are for women only and 1% for men only; 24% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Gastrointestinal Diseases studies take

Of 23 phase 2 interventional studies under Gastrointestinal Diseases, half reached primary completion within 31 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 231 mo21–46 · 23 studies——
Phase 334 mo23–48 · 21 studies——
Interventional, no phase24 mo10–45 · 149 studies—26 mo11–46 · 127 studies
Observational65 mo24–155 · 65 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting3

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 548. Browse all 548 → or search them.